AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Carmell Therapeutics Corp... (CTCX)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

0.45

-9.09%

At close: Jan 10, 2025, 3:59 PM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21
Revenue	n/a	n/a	n/a
Cost of Revenue	124.79K	242.56K	n/a
Gross Profit	-124.79K	-242.56K	n/a
Operating Income	-5.22M	-5.51M	-1.94M
Interest Income	n/a	2.25M	8.09K
Pretax Income	-16.21M	-9.05M	-6.48M
Net Income	-15.45M	-9.05M	-6.48M
Selling & General & Admin	2.60M	3.22M	863.33K
Research & Development	2.50M	2.20M	982.84K
Other Expenses	n/a	10.92K	37.38K
Operating Expenses	5.09M	5.51M	1.94M
Interest Expense	889.32K	3.75M	2.50M
Selling & Marketing Expenses	n/a	n/a	n/a
Cost & Expenses	5.22M	5.51M	1.94M
Income Tax	-760.16K	391.20K	2.54M
Shares Outstanding (Basic)	11.02M	19.77M	19.77M
Shares Outstanding (Diluted)	11.02M	19.77M	19.77M
EPS (Basic)	-1.46	-0.46	-0.33
EPS (Diluted)	-1.46	-0.46	-0.33
EBITDA	-15.19M	-5.25M	-1.66M
Depreciation & Amortization	124.79K	242.56K	242.12K